Raanan Berger

机构：Tel Aviv University, Sheba Medical Center, Peres Academic Center · ORCID：0000-0002-2788-0971

发表论文 331 篇 · 总被引 14877 次 · h-index 49

代表论文

• Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study (2024 · Journal of Clinical Oncology · 被引 176)
• Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial (2024 · Annals of Oncology · 被引 58)
• Avelumab + axitinib vs sunitinib in patients (pts) with advanced renal cell carcinoma (aRCC): Final overall survival (OS) analysis from the JAVELIN Renal 101 phase 3 trial. (2024 · Journal of Clinical Oncology · 被引 26)
• Modeling epithelial-mesenchymal transition in patient-derived breast cancer organoids (2024 · Frontiers in Oncology · 被引 12)
• Combination Treatment of Intratumoral Vidutolimod, Radiosurgery, Nivolumab, and Ipilimumab for Microsatellite Stable Colorectal Carcinoma With Liver Metastases (2023 · Clinical Colorectal Cancer · 被引 7)
• Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine: Bringing next-generation precision oncology to patients (2025 · Oncotarget · 被引 6)